CFO appointment
Ocular Therapeutix, Inc. appoints Jason Robins as CFO
Ocular Therapeutix, Inc. reported in a Form 8-K filed June 12, 2026 that Jason Robins was appointed Chief Financial Officer, effective June 10, 2026.
In the filing's words
On June 10, 2026, the Board appointed Jason Robins, the Company’s interim Chief Financial Officer, to serve as the Chief Financial Officer. Mr. Robins is continuing to serve as the Company’s principal financial officer and principal accounting officer.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Ocular Therapeutix, Inc. (OCUL) |
|---|---|
| Event | Appointment |
| Incoming | Jason Robins |
| Title in the filing | Chief Financial Officer |
| Effective | June 10, 2026 |
| 8-K filed | June 12, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | interim Chief Financial Officer, OCULAR THERAPEUTIX, INC. |
| SEC CIK | 0001393434 |
OCULAR THERAPEUTIX, INC. reported this change in a Form 8-K, Item 5.02, filed June 12, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Jason Robins? Send a correction with the primary source.